Registry of patients undergoing heart revascularization procedures
Official title: Barts Revascularisation Registry - To Understand the Characteristics, Time-trends and Outcomes in Patients With Coronary Artery Disease at Barts Heart Centre
Run by Queen Mary University of London · NCT05255705 · Data updated 2026-11-12
This study collects information on patients with coronary artery disease who have heart procedures to see how well they do and what factors affect their recovery.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 20000 (estimated) |
| Sponsor | Queen Mary University of London Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | August 6, 2021 |
| Main results expected | March 30, 2030 |
| Study ends | March 30, 2030 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT05255705 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are adults aged 16 and older who have undergone angiography and revascularization procedures at the participating center.
✕Probably not a fit
Patients under 16 years of age or those who have not undergone revascularization procedures will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study collects data on patients with coronary artery disease (CAD) who undergo percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG) at one of the largest cardiac centers in Europe. The aim is to assess patient characteristics, outcomes, and predictors of success in real-world settings, contributing to the understanding of treatment efficacy and safety. The study utilizes a password-protected clinical database that includes demographic, clinical, and outcome data from a large cohort of patients over several years.
Why it matters
Potential benefit: If successful, this study could enhance the understanding of treatment outcomes for patients with CAD, leading to improved risk stratification and personalized care.
How similar studies have gone: Other studies have successfully utilized observational data to improve treatment strategies for CAD, indicating that this approach is both valuable and established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Informed consent will not be sought for, as patients are automatically included onto a database that we will use for research purposes. * No children will be included in this study. * Vulnerable adults or those unable to give consent will be included in the study as well if they are referred to the Interventional Cardiology team. * Both male and female patients ≥16 years of age will be included * All patients will have had an angiogram at BHC. * Any patient who has undergone revascularisation. Exclusion Criteria: • Patients \<16 years will not be included in this study.
Where it's running
-
Barts Health NHS Trust
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Dr. Krishnaraj Rathod
- Email: krishnaraj.rathod1@nhs.net
- Phone: 02073773000
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using telemedicine for home-based cardiac rehabilitation
This study is testing whether a home-based heart rehab program using telemedicine can help people improve their health and quality of life after heart issues.
-
Heart@Home: Safe, at-home care for people with acute heart problems compared with hospital care
This trial tests whether hospital-level care at home can safely and effectively treat adults with acute heart conditions who would normally be in the hospital.
-
Digital cardiac rehab to help heart attack patients improve function
A digital health–supported cardiac rehabilitation program is being tested to see if it helps people after a heart attack improve fitness and stay engaged with rehab, compared with standard outpatient rehab.
-
NMR-based Risk Test and Digital Health Support for midlife adults in Eloisa
This study tests whether an NMR metabolomics risk test can guide tailored digital health programs for midlife adults at risk of diabetes, heart disease, stroke, kidney disease, or fatty liver.
-
See if stopping long-term aspirin is as good as continuing it in older adults with stable ischemic heart disease
In adults 65 and older with stable ischemic heart disease, this trial tests whether stopping daily low-dose aspirin is not worse than continuing it.
-
Innate Immune Cells and Early Fibrotic Repair After a Heart Attack
This study tests whether specific neutrophil and monocyte patterns are linked to early scar formation after a heart attack in STEMI patients.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.